The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

5 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of new stabilized combi-triazenes for targeting solid tumors expressing the epidermal growth factor receptor (EGFR) or its closest homologue HER2.EBI
Mcgill University/Royal Victoria Hospital
Optimization of novel combi-molecules: identification of balanced and mixed bcr-abl/DNA targeting properties.EBI
Mcgill University/Royal Victoria Hospital
Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status.EBI
Mcgill University/Royal Victoria Hospital
Synthesis of pyrimidinopyridine-triazene conjugates targeted to abl tyrosine kinase.EBI
Mcgill University/Royal Victoria Hospital
NHE3-binding compounds and methods for inhibiting phosphate transportBDB
Ardelyx